Expanding Australia's bowel cancer research capacity
Bowel Cancer Australia plans to expand Australia's capacity for bowel cancer research through the establishment of an inaugural endowed chair in bowel cancer research.
Bowel Cancer Australia intends to recruit an expert with a world class record in research and/or clinical practice. The position will help to attract and retain some of the best and brightest clinical scientists, researchers, physicians and surgeons from around the world to work with the chair.
To be located at the University of Sydney's Northern Clinical School, the chair will build upon existing research expertise in bowel cancer.
Valuable research bench space has already been secured in the $95 million purpose built state-of-the-art research and education facility.
The chair will provide exciting new growth opportunities in bowel cancer research and education, benefiting the Australian community.
The initiative received a $1million funding commitment from Patron, Mr Richard Penn.
In recognition of the Penn family's generous commitment, the chair is to be named the Lawrence Penn Chair in Bowel Cancer Research after Mr Penn's father, a bowel cancer survivor.
Bowel Cancer Australia will further seek to raise additional funds that will endow and secure this inaugural post in perpetuity.
Donations and gifts made to the chair in bowel cancer research will be permanently invested, with only the income spent each year to support the salary of the chair holder as well as the appointee's related research and educational activities.
An endowed chair in bowel cancer research
Endowed chairs are recognised as a University's finest scholar in their field of expertise and accorded appropriate prestige and recognition.
They provide a research focal point for countries in which they are located, enabling them to build outstanding reputations in their field of expertise.
The benefits of establishing an endowed chair are many, with the holder setting the pace at various levels. They spur colleagues to their finest efforts in research; they encourage graduate students in their chosen careers; they teach undergraduates at a time when they are deciding on their major field of study, thus influencing them for life.
The prestige associated with an endowed chair will help Australia attract and retain some of the brightest future clinical scientists, researchers, physicians and surgeons. This will provide new growth opportunities in education and research, as well as maintain service in bowel cancer research and practice at the very highest level – benefiting the entire Australian community.
The aim will be to recruit a world-class research leader in the area of cause, prevention and treatment of bowel cancer by 2016.